Dtf & Dtf 1 Te E Gyan May 19

30 Questions | Total Attempts: 285

SettingsSettingsSettings
Dtf & Dtf 1 Te E Gyan May 19 - Quiz

. Welcome to TE E-GYAN Test Here is an opportunity to test your Product knowledge. You have 30 minutes to complete this test. Please enter your Name , Emp. Code ,HQ and Select your state. Then press "Start" to begin the test. You can only attend the test once and hence make sure you have uninterrupted internet connectivity. All the best Micro Leadership Academy


Questions and Answers
  • 1. 
    The only Sulphonyl Urea which is Cardioprotective
    • A. 

      Glimepride

    • B. 

      Glibenclamide

    • C. 

      Gliclazide

    • D. 

      All of the Above

  • 2. 
    Metformin is a insulin sensitiser. Which are the other OHAs which are insulin sensitiser
    • A. 

      Pioglitazone

    • B. 

      Glinides

    • C. 

      Acarbose

    • D. 

      Miglitol

  • 3. 
    Glinides: Repaglinide, Mitiglinide and Nataglinide
    • A. 

      These are short acting agents with a mechanism of action similar to sulphonylureas as insulin secretagogues. These agents are very effective in reducing postprandial blood glucose.

    • B. 

      These are Drugs that reduce the insulin resistance at the cellular level.

    • C. 

      These are Drugs that act on insulin resistance at peripheral cells & alos have a lipid lowering profile.

    • D. 

      These Reversibly inhibits the alpha glucosidase enzymes responsible for the breaking down and absorption of carbohydrates

  • 4. 
    Alphaglucosidase inhibitors: Voglibose, Acarbose, Miglitol
    • A. 

      These are short acting agents with a mechanism of action similar to sulphonylureas as insulin secretagogues. These agents are very effective in reducing postprandial blood glucose.

    • B. 

      These are Drugs that reduce the insulin resistance at the cellular level.

    • C. 

      These are Drugs that act on insulin resistance at peripheral cells & alos have a lipid lowering profile.

    • D. 

      These Reversibly & competitively inhibits the alpha glucosidase enzymes responsible for the breaking down and absorption of carbohydrates

  • 5. 
    Dipeptidyl Peptidase: IV inhibitors (DPP-IV inhibitors):- - Sitagliptin, Saxagliptin, Vildagliptin & Linagliptin.
    • A. 

      These are short acting agents with a mechanism of action similar to sulphonylureas as insulin secretagogues. These agents are very effective in reducing postprandial blood glucose.

    • B. 

      These are Drugs that reduce the insulin resistance at the cellular level.

    • C. 

      These are Drugs that act on insulin resistance at peripheral cells & alos have a lipid lowering profile.

    • D. 

      They act by decreasing the breakdown of GLP-1 (Glucagon like Peptide) by extending the half life of endogenous GLP – 1.

  • 6. 
    There are mainly two reasons for Type 2 diabetes
    • A. 

      Micro and Macro Vascular Complications

    • B. 

      ID & IR

    • C. 

      Peripheral Arterial Disease and Stroke

    • D. 

      Diet and Exercise

  • 7. 
    Microvascular Complications
    • A. 

      Neuropathy

    • B. 

      Retinopathy

    • C. 

      Neuropathy

    • D. 

      All of the Above

  • 8. 
    USP of Telrose
    • A. 

      FDC improves patients compliance

    • B. 

      The FDC is pro equvalant to co administration of seperate tablets

    • C. 

      Decreses HOMA-IR by 29%&hr-CRP by 44%

    • D. 

      All of the Above

  • 9. 
    Atherosclerosis, a form of arteriosclerosis,
    • A. 

      Is the reduction in blood flow through the arteries caused by greasy deposits called plaque that form on the insides of arteries and partially restrict the flow of blood.

    • B. 

      Commonly known as hardening of the arteries, the walls of the arteries thicken, harden, and lose their elasticity. The heart must work harder than normal to deliver

    • C. 

      Both of above

    • D. 

      None of the above

  • 10. 
    Causes of CHF
    • A. 

      HTN & CAD

    • B. 

      Cardiomyopathy

    • C. 

      Valvular Heart Disease / Adult Congenital Heart Disease

    • D. 

      All of the Above

  • 11. 
    Symptoms of LVH
    • A. 

      increasing shortness of breath with activity and while lying flat

    • B. 

      cough, palpitations, fatigue

    • C. 

      Decreased urine production and waking in the middle of the night with difficulty breathing

    • D. 

      All of the Above

  • 12. 
    DIAPRIDE 3S
    • A. 

      Smarter Safer Superior

    • B. 

      Superior , Smarter, Sensible,

    • C. 

      Smarter, Sensible, Safer

    • D. 

      Smarter, Safer, Sensitive, Sensible

  • 13. 
    Brand Promise of Telrose
    • A. 

      CardioProtection

    • B. 

      Renal Protection

    • C. 

      A promise to Protect

    • D. 

      Cardiorenal protection

  • 14. 
    Brand Promise of Pregator
    • A. 

      Scores on Total Neuropathy Care

    • B. 

      Total Neuropathy care

    • C. 

      Total 360 care

    • D. 

      Complete care

  • 15. 
    Brand Promise of Meconerv Plus
    • A. 

      Recharges nerves for smooth conduction

    • B. 

      Recharge with Complete Nerve Antioxidant

    • C. 

      Recharges Nerves, Recharges life

    • D. 

      In Hypertension, Diabetes, Cognitive Decline

  • 16. 
    Dr. Calls/Month
    • A. 

      Rs. 500 - Meet minimum 90% of expected 300 doctor calls in the month

    • B. 

      Rs. 600 - Meet minimum 80% of expected 300 doctor calls in the month

    • C. 

      Rs. 750 - eet minimum 70% of expected 300 doctor calls in the month

    • D. 

      Rs. 500 - Meet minimum 95% of expected 300 doctor calls in the month

  • 17. 
    Core Dr Visit compliance
    • A. 

      Rs. 500 - Minimum 90% visit compliance of all core doctors (2/3 visits) as defined by division

    • B. 

      Rs. 650 - Minimum 95% visit compliance of all core doctors (2/3 visits) as defined by division

    • C. 

      Rs. 500 - Minimum 100% visit compliance of all core doctors (2/3 visits) as defined by division

    • D. 

      Rs. 750 - Minimum 100% visit compliance of all core doctors (2/3 visits) as defined by division

  • 18. 
    Complete filling of RCPA, Detailing of brands, Samples and gift distribution , POBS
    • A. 

      Rs. 500 - Minimum for core and targeted doctors

    • B. 

      Rs. 600 - Minimum for core and targeted doctors& Chemist

    • C. 

      Rs. 750 - Minimum for core and targeted doctors,Chemsit & Stockist

    • D. 

      Rs. 500 - Minimum for core and targeted doctors,Chemist ,Stockist & c&f

  • 19. 
    Early Sales Closing
    • A. 

      Rs. 500 - Achieve 70% of your sales by 21st of the month

    • B. 

      Rs. 750 - Achieve 70% of your sales by 22 ndof the month

    • C. 

      Rs. 600 - Achieve 70% of your sales by 31st of the month

    • D. 

      Rs. 100 - Achieve 70% of your sales by 20th of the month

  • 20. 
       Disbursement will be quarterly (You should not have negative growth to earn call average, compliance, RCPA Norms incentive, with reporting schedule as per Company norms.)
    • A. 

      True

    • B. 

      False

  • 21. 
    If PCPM is 1.5 Lac and growth is >=35% How much incentive TE will get
    • A. 

      3000

    • B. 

      3150

    • C. 

      2500

    • D. 

      3370

  • 22. 
    If PCPM is 2.5 Lac and growth is >=30% how much incentive TE will earn
    • A. 

      8400

    • B. 

      8000

    • C. 

      8800

    • D. 

      8700

  • 23. 
    Growth is calculated as
    • A. 

      LYS-CYS/LYS

    • B. 

      CYS-LYS/LYS

    • C. 

      LY/CY*100

    • D. 

      (CYS-LYS/LYS)*100

  • 24. 
    TE PCPM is 3.80 lac and growth is >=25% what will his total earning of incentive
    • A. 

      12600

    • B. 

      13702

    • C. 

      12000

    • D. 

      13000

  • 25. 
    If PCPM is 4.75 and growth is >30% what the incentive TE will get
    • A. 

      20900

    • B. 

      20650

    • C. 

      21600

    • D. 

      20000

Related Topics
Back to Top Back to top